$VEEV

Veeva Systems Inc. Stock 12‑Month Price Target Raised to $301.08, Implies 7% Downside

Veeva Systems Inc.'s average stock price target increased from $299.15 to $301.08, with a range of $180 to $360, according to 26 analysts. This implies a 7% downside from the Oct. 22 closing price. The consensus rating remains 'Buy' among 32 analysts.

Original reporting
Published Oct 23, 2026, 4:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 24, 2026, 7:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Veeva Systems Inc. Stock 12‑Month Price Target Raised to $301.08, Implies 7% Downside — source image
Decision brief

The 30-second read

$VEEVNeutralLow
01

Why it matters

The target raise reflects analyst optimism but the implied downside tempers expectations, likely limiting near‑term buying pressure.

02

Market read

A modest price‑target increase with a downside implication offers limited trading impetus.

03

What to watch

The target range remains wide ($180‑$360), indicating uncertainty that could be exploited by swing traders.

Relevance 5/10Novelty 4/10Timing: post‑market today

Background

Veeva Systems is a cloud‑based software provider for life‑sciences companies; analyst coverage is extensive.

Company-level read

Ticker impact

$VEEVNeutralHigh confidence
Context

Analyst consensus price target raised to $301.08, implying about 7% downside from the recent close.

Expected impact

likely slight pressure as the market prices in the modest upside but downside implication

Evidence & confidence

Price target moves are a direct signal to investors; a higher target with a downside implication can curb bullish sentiment.

Market effects

Minimal impact on the broader cloud‑software sector; price‑target updates are company‑specific.

None

Low

Counterpoint

Some investors may view the higher target as a sign of lingering upside potential despite the implied downside.

Key entities

  • Veeva Systems Inc.

    Provider of cloud‑based software for the life‑sciences industry.

Related articles

$VEEVHigh

Veeva Systems (VEEV) Stock Trades Up, Here Is Why

Veeva Systems (VEEV) stock rose 2.8% after expanding its partnership with IQVIA, which adopted Veeva's clinical operations software. The company reported Q2 revenue of $928M, up 17.6% YoY, beating estimates. VEEV raised full-year revenue guidance to $3.68B and adjusted earnings outlook to $9.21 per share. The stock is up 37% YTD and hit a 52-week high.

$VEEVMed

CFRA upgrades Veeva Systems (VEEV) to a Buy

CFRA upgraded Veeva Systems (VEEV) to Buy with a new price target. The consensus rating is Moderate Buy with an average target of $293.57. Veeva reported Q2 revenue of $927.96M and net profit of $273.43M, up from $789.08M and $200.31M last year. Insider sentiment is negative, with 63 insiders selling shares.

$VEEVHighAI 8/10

Michael Burry Remains Bullish on Veeva but Trimmed His Position. What This Means for VEEV Stock.

Veeva Systems reported a 37% increase in net income to $273.4M and raised fiscal 2027 revenue guidance to $3.682B-$3.687B. Michael Burry trimmed his position but remains bullish, citing the company's intrinsic value and growth potential. Analysts expect Q3 EPS of $1.68 and have raised price targets, with a consensus 'Moderate Buy' rating and $292.52 average target.

$VEEVMedAI 8/10

Veeva Rises on Sales and Margin Gains, Guidance Raise

Veeva Systems (VEEV) reported Q2 fiscal 2027 revenue of $928M, up 18% YoY, with non-GAAP operating income of $415.9M. The company raised guidance to $3.687B in revenue and $9.21 in non-GAAP EPS. VEEV shares have risen 25% YTD, supported by strong institutional demand and robust fundamentals, including 3-year sales and EPS growth rates of 14.1% and 21.6%, respectively.

$VEEVHighAI 8/10

Watch Veeva, CrowdStrike, and More

Veeva Systems (VEEV) reported Q2 non-GAAP EPS of $2.35, revenue growth of 17.6% Y/Y to $928M, and raised its Q3 revenue forecast. CrowdStrike (CRWD) posted 25.6% Y/Y revenue growth to $1.47B. Dycom Industries (DY) fell 11.6% despite 45.6% Y/Y revenue growth to $2.01B due to segment pressures and higher costs.